Get startedLog in
    Picture of BRAIN Biotech AG logo

    BNN — BRAIN Biotech AG Income Statement

    0.000.00%
    de flag iconLast trade - 00:00
    IndustrialsHighly SpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for BRAIN Biotech AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

    2020
    September 30th
    2021
    September 30th
    2022
    September 30th
    2023
    September 30th
    2024
    September 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue39.139.250.356.255.5
    Cost of Revenue
    Gross Profit2222.428.23131.2
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses47.345.855.961.764.4
    Operating Profit-8.23-6.55-5.65-5.48-8.85
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-9.94-4.28-6.17-7.49-11
    Provision for Income Taxes
    Net Income After Taxes-9.02-4.68-6.34-8.11-11.1
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-9.68-4.97-6.59-8.28-11.1
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-9.68-4.97-6.59-8.28-11.1
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.391-0.267-0.307-0.371-0.509
    Dividends per Share